Description
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 7
Primary Industries
- Cannabis
- Tobacco
- Drugs
- E-Cigarette
- Food
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 365842
IPSCIO Record ID: 27719
The Licensor will be responsible for the active ingredient and will source and qualify the CBD oil and will formulate the contents of the pre-filled cartridges and refill units.
This new product will utilize Licensee's patent pending, proprietary device that dispenses a measured and consistent amount of active ingredient per puff and that also features an optional childproofing device.
IPSCIO Record ID: 362604
Licensor hereby assigns, transfers and conveys to XXII all right, title and interest in and to the Results. Licensor shall execute and deliver to XXII such documents, instrument and other writings reasonably requested by XXII to vest all right, title and interest in the Results in XXII.
Non-Licensor Identified Targets means Results that constitute or are based on genes, alleles and other regulators that are publicly known regulatory elements.
Project Technology Results means (i) any and all protocols, methods, procedures, know-how, software, inventions, technologies and/or combinations thereof, whether in electronic form or not and whether or not laid down in protocols that (A) is developed, created and/or generated by Licensor from the execution of a Project, (B) is applicable to the Field, and (C) is expressly a deliverable of a Project as further detailed in a PAS and/or is otherwise expressly agreed by the Parties prior to the commencement of a respective Project as being a Project Technology Result, unless otherwise agreed to in writing by the Parties after the commencement of a Project and (ii) any other protocols, methods, procedures or technologies that may be separately approved by the Steering Committee as Project Technology Results.
Licensor is a global leader in plant research involving high-value genetic traits and increased crop yields.
The focus of the collaboration will include
(i) Creating a cutting-edge genetic database which utilizes the results of genomic analyses of several hundred existing, exceptional hemp/cannabis plant lines for use in the acceleration of the Company’s development and licensing of uniquely characterized and improved hemp/cannabis plants;
(ii) Enhancing genetic variation to empower Licensee’s development of new and significantly improved varieties of hemp/cannabis plant lines and varieties with highly desirable cannabinoid profiles optimized for medicinal or therapeutic applications;
(iii) Creating a proprietary and industry-leading high-resolution “molecular genetic map†of the entire cannabis plant genome to facilitate rapid, cost-effective breeding of innovative varieties of hemp/cannabis plants with distinctive agronomic traits;
(iv) Analyzing the genomic sequences of multiple species of the hemp/cannabis plant and identifying shared genetic markers, allowing Licensee to develop improved commercial hemp/cannabis plant lines more rapidly than through conventional plant breeding approaches; and
(v) Initiating the rapid-cycle generation of hemp/cannabis plant lines with distinctive cannabinoid and terpene profiles to create elite lines.
Licensor provides Licensee access to a unique suite of crop innovation platforms, including genomics, molecular genetics, trait discovery and breeding technologies.
IPSCIO Record ID: 301640
The Licensed Science Sublicense granted is for the purpose of engaging in the business of treating, producing, manufacturing, marketing and selling Licensed Products.
The Licensed Science as its relates to the production, methods, and products of CBD and its derivatives.
(a) production and manufacturing of CBD, CBD byproducts and CBD derivatives, from non-psychoactive, low-THC cannabis sativa plant strains and cannabinoids (collectively, Cannabis), for Sale and use at retail or wholesale where permitted, including, without limitation, CBD food additives, CBD edibles, and CBD hemp variations of the foregoing;
(b) CBD-related research, teaching and education for both medical and other purposes; and
(c) all medical uses and applications of CDB.
The Field is exclusive to production, methods, and products of CBD and its derivatives, and excludes and prohibits any THC related products having measurable tetrahydrocannabinol concentration potency above 3.0% on a dry weight basis, production methods, techniques, or Know How.
IPSCIO Record ID: 366321
Non-Licensee Identified Targets means Results that constitute or are based on genes, alleles and other regulators that are publicly known regulatory elements.
Project Technology Results means (i) any and all protocols, methods, procedures, know-how, software, inventions, technologies and/or combinations thereof, whether in electronic form or not and whether or not laid down in protocols that (A) is developed, created and/or generated by Licensee from the execution of a Project, (B) is applicable to the Field, and (C) is expressly a deliverable of a Project as further detailed in a PAS and/or is otherwise expressly agreed by the Parties prior to the commencement of a respective Project as being a Project Technology Result, unless otherwise agreed to in writing by the Parties after the commencement of a Project and (ii) any other protocols, methods, procedures or technologies that may be separately approved by the Steering Committee as Project Technology Results.
IPSCIO Record ID: 229839
Property includes any and all licensed products manufactured using cannabis infused oils, tinctures, butters, for topical and ingestible use.
IPSCIO Record ID: 266631
Licensor grants an exclusive license to all Licensors Intellectual Property and patented technology and creates a partnership to bring their patented controlled cavitation process to the cannabis industry.
Licensor is the owner of certain Technology called ShockWave Powerâ„¢. Licensor owns Intellectual Property (“IPâ€, defined below), manifested in Patents, Trade Secrets, and Know How, which are embodied in Licensor's proprietary ShockWave Power Reactor/Extractor (“SPRâ„¢), and which IP is useful in a variety of industries including but not limited to those industries that extract, mix, heat, hydrate, homogenize and crystallize materials.
“Cannabis Industry†means the industry where cannabis oils and other compounds containing cannabis (“Cannabis Materialsâ€, defined below) are derived from the cannabis sativa, cannabis indica, and cannabis ruderalis plants, including marijuana and hemp, either singularly or by mixing with substances other than cannabis oils.
“Cannabis Application†means the use of the Licensor Technology to achieve a specific result when processing only “Cannabis Materialsâ€.
“ShockWave Power Reactor/Xtractor (SPRâ„¢â€) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.
“ShockWave Power Reactor/Xtractor (SPRâ„¢â€) means HDI’s proprietary device that embodies the HDI Technology in performing multiple heating, mixing and extraction functions.
“Standalone SPR†means an SPR mounted on a skid containing no other equipment other than that necessary to run the SPR.
(i) UV light for decarboxylation of THC
(ii) Crystallization of CBD or THC
(iii) mixing of cannabis oil with other substances to create foods, beverages, or other products which are themselves not cannabis oils
(iv) Use of Electrochemistry or UltraViolate (UV) SPR’s or other advanced oxidation materials to produce radicals for the production of CBN
(v) Hydrogenation of cannabis oils
(vi) processing of hemp oils for biofuels.
(vii) Development of an SPR for supercritical CO2